1887

Abstract

Shiga toxins (Stxs) produced by enterohaemorrhagic or damage human endothelial cells predominantly in cooperation with pro-inflammatory cytokines, such as TNF-. However, in this study, IFN- pre-treatment resulted in human lung microvascular endothelial cells becoming over 10 000-fold less sensitive to Stxs. In contrast, in their basal condition, they were extremely sensitive to Stxs. Interestingly, TNF- addition to IFN- reverted the Stx-resistant phenotype, which corresponded with its well-established enhancing effect on Stx toxicity. Toxin binding to the cell was barely affected by IFN-. Also, the toxin uptake in the Stx-resistant phenotype was more than 100-fold greater than that of normal cells, when compared at Stx concentrations resulting in equivalent degrees of cell damage. Protein synthesis was inhibited by nearly 90 % in the Stx-resistant phenotype after 24 h toxin exposure. This indicated that the intracellular toxin was active as an -glycosidase, while cells were still over 60 % viable, suggesting a possible unknown cytotoxic function of Stx. In conclusion, this study shows a unique effect of IFN- in the suppression of the toxicity of Stxs in a human microvascular endothelial cell model and the involvement of a novel mechanism in this suppression.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.26142-0
2003-09-01
2019-10-23
Loading full text...

Full text loading...

/deliver/fulltext/micro/149/9/mic1492609.html?itemId=/content/journal/micro/10.1099/mic.0.26142-0&mimeType=html&fmt=ahah

References

  1. Arab, S. & Lingwood, C. A. ( 1998; ). Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic. J Cell Physiol 177, 646–660.[CrossRef]
    [Google Scholar]
  2. Banatvala, N., Griffin, P. M., Greene, K. D., Barrett, T. J., Bibb, W. F., Green, J. H., Wells, J. G. & Hemolytic Uremic Syndrome Study Collaborators ( 2001; ). The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183, 1063–1070.[CrossRef]
    [Google Scholar]
  3. Bhimma, R., Rollins, N. C., Coovadia, H. M. & Adhikari, M. ( 1997; ). Post-dysenteric hemolytic uremic syndrome in children during an epidemic of Shigella dysentery in Kwazulu/Natal. Pediatr Nephrol 11, 560–564.[CrossRef]
    [Google Scholar]
  4. Decludt, B., Bouvet, P., Mariani-Kurkdjian, P., Grimont, F., Grimont, P. A., Hubert, B. & Loirat, C. ( 2000; ). Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Societe de Nephrologie Pediatrique. Epidemiol Infect 124, 215–220.[CrossRef]
    [Google Scholar]
  5. Eisenhauer, P. B., Chaturvedi, P., Fine, R. E., Ritchie, A. J., Pober, J. S., Cleary, T. G. & Newburg, D. S. ( 2001; ). Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin. Infect Immun 69, 1889–1894.[CrossRef]
    [Google Scholar]
  6. Endo, Y., Tsurugi, K., Yutsudo, T., Takeda, Y., Ogasawara, T. & Igarashi, K. ( 1988; ). Site of action of a Vero toxin (VT2) from Escherichia coli O157 : H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 171, 45–50.[CrossRef]
    [Google Scholar]
  7. Garred, O., van Deurs, B. & Sandvig, K. ( 1995; ). Furin-induced cleavage and activation of Shiga toxin. J Biol Chem 270, 10817–10821.[CrossRef]
    [Google Scholar]
  8. Gianviti, A., Rosmini, F., Caprioli, A., Corona, R., Matteucci, M. C., Principato, F., Luzzi, I. & Rizzoni, G. ( 1994; ). Haemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy. Italian HUS Study Group. Pediatr Nephrol 8, 705–709.[CrossRef]
    [Google Scholar]
  9. Guardabasso, V., Munson, P. J. & Rodband, D. ( 1988; ). A versatile method for simultaneous analysis of families of curves. FASEB J 2, 209–215.
    [Google Scholar]
  10. Karmali, M. A., Petric, M., Lim, C., Fleming, P. C., Arbus, G. S. & Lior, H. ( 1985; ). The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151, 775–782.[CrossRef]
    [Google Scholar]
  11. Keusch, G. T., Acheson, D. W., Aaldering, L., Erban, J. & Jacewicz, M. S. ( 1996; ). Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells. J Infect Dis 173, 1164–1170.[CrossRef]
    [Google Scholar]
  12. Kondo, F., Kobayashi, S., Matsumoto, K., Yamada, S., Saito, M., Suzuki, Y., Ishikawa, N., Nakanishi, T. & Shimizu, A. ( 1997; ). Analysis of Vero toxins 1 and 2 by high-performance liquid chromatography/electrospray ionization mass spectrometry. J Mass Spectrom 32, 1140–1142.[CrossRef]
    [Google Scholar]
  13. Laurence, J. & Mitra, D. ( 1997; ). Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic syndrome. Semin Hematol 34, 98–105.
    [Google Scholar]
  14. Molostvov, G., Morris, A., Rose, P. & Basu, S. ( 2001; ). Interaction of cytokines and growth factor in the regulation of verotoxin-induced apoptosis in cultured human endothelial cells. Br J Haematol 113, 891–897.[CrossRef]
    [Google Scholar]
  15. Ohmi, K., Kiyokawa, N., Takeda, T. & Fujimoto, J. ( 1998; ). Human microvascular endothelial cells are strongly sensitive to Shiga toxins. Biochem Biophys Res Commun 251, 137–141.[CrossRef]
    [Google Scholar]
  16. Pijpers, A. H., van Setten, P. A., van den Heuvel, L. P., Assmann, K. J., Dijkman, H. B., Pennings, A. H., Monnens, L. A. & van Hinsbergh, V. W. ( 2001; ). Verocytotoxin-induced apoptosis of human microvascular endothelial cells. J Am Soc Nephrol 12, 767–778.
    [Google Scholar]
  17. Siegler, R. L., Pysher, T. J., Tesh, V. L. & Taylor, F. B., Jr ( 2001; ). Response to single and divided doses of Shiga toxin-1 in a primate model of hemolytic uremic syndrome. J Am Soc Nephrol 12, 1458–1467.
    [Google Scholar]
  18. Taylor, F. B., Jr, Tesh, V. L., DeBault, L., Li, A., Chang, A. C., Kosanke, S. D., Pysher, T. J. & Siegler, R. L. ( 1999; ). Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1. Am J Pathol 154, 1285–1299.[CrossRef]
    [Google Scholar]
  19. van de Kar, N. C., Monnens, L. A., Karmali, M. A. & van Hinsbergh, V. W. ( 1992; ). Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80, 2755–2764.
    [Google Scholar]
  20. Wanders, R. J. A., Romeyn, G. J., Schutgens, R. B. H. & Tager, J. M. ( 1989; ). l-Pipecolate oxidase: a distinct peroxisomal enzyme in man. Biochem Biophys Res Commun 164, 550–555.[CrossRef]
    [Google Scholar]
  21. Wang, J. H., Redmond, H. P., Watson, R. W., Condron, C. & Bouchier-Hayes, D. ( 1999; ). Involvement of tyrosine protein kinase in IFN-gamma-induced human endothelial cell apoptosis. Shock 11, 311–318.[CrossRef]
    [Google Scholar]
  22. Wills, R. J. ( 1990; ). Clinical pharmacokinetics of interferons. Clin Pharmacokinet 19, 390–399.[CrossRef]
    [Google Scholar]
  23. Yoshida, T., Fukada, M., Koide, N., Ikeda, H., Sugiyama, T., Kato, Y., Ishikawa, N. & Yokochi, T. ( 1999; ). Primary cultures of human endothelial cells are susceptible to low doses of Shiga toxins and undergo apoptosis. J Infect Dis 180, 2048–2052.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.26142-0
Loading
/content/journal/micro/10.1099/mic.0.26142-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error